Schedule 13D ownership disclosure

Stealth BioTherapeutics Corp

Security class unavailable · CUSIP: 85788D100

Event date: 2019-02-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
64.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-057665
Form type
SC 13D
Filer
Equal Talent Investments Ltd
CIK
CIK 1769229
Filed
Feb 28, 2019
Reporting period
Feb 20, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub